{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T16:29:11Z","timestamp":1757780951982},"reference-count":14,"publisher":"Mark Allen Group","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dent Update"],"published-print":{"date-parts":[[2014,6,2]]},"abstract":"<jats:p> Post-operative haemorrhage is a recognized complication in dental practice. This may be more prevalent in patients taking anti-thrombotic medications. It is important that the dentist understands the mechanism of action of these drugs and how they may affect management of dental patients. <\/jats:p><jats:p> Clinical Relevance: Dental professionals must be aware of those medications affecting haemostasis and how they may impact on management. The emergence of different therapeutic regimens has increased the number of such drugs. <\/jats:p>","DOI":"10.12968\/denu.2014.41.5.395","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T10:21:49Z","timestamp":1501582909000},"page":"395-405","source":"Crossref","is-referenced-by-count":11,"title":["Haemostasis part 2: medications that affect haemostasis"],"prefix":"10.12968","volume":"41","author":[{"given":"Neal J","family":"McCormick","sequence":"first","affiliation":[{"name":"General Professional Trainee (GPT), Health Education North East"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Undrell J","family":"Moore","sequence":"additional","affiliation":[{"name":"Senior Lecturer in Oral Surgery, Newcastle Dental Hospital, Richardson Road, Newcastle upon Tyne, NE2 4AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G","family":"Meechan","sequence":"additional","affiliation":[{"name":"Honorary Consultant\/Senior Lecturer in Oral Surgery, Newcastle Dental Hospital, Richardson Road, Newcastle upon Tyne, NE2 4AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Norouzi","sequence":"additional","affiliation":[{"name":"Specialist Registrar in Haematology, Royal Victoria Infirmary, Newcastle upon Tyne (Health Education North East), UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5130","reference":[{"key":"B1","unstructured":"British National Formulary 63. London: BMJ Group and Pharmaceutical Press, March 2012."},{"key":"B2","unstructured":"National Institute for Health and Clinical Excellence (NICE). Technology Appraisal guidance 182: Acute coronary syndrome \u2013 prasugrel: understanding NICE guidance. London: NICE, October 2009."},{"key":"B3","unstructured":"National Institute for Health and Clinical Excellence (NICE). Technology Appraisal guidance 236: Ticagrelor for the treatment of acute coronary syndromes. London: NICE, October 2011."},{"key":"B4","unstructured":"National Institute for Health and Clinical Excellence (NICE). Clinical guideline 94: Unstable Angina and NSTEMI. London: NICE, March 2010."},{"issue":"5","key":"B6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2796.2005.01477.x","volume":"257","author":"Burger W","year":"2005","journal-title":"J Intern Med"},{"key":"B7","doi-asserted-by":"crossref","unstructured":"Keeling D, Baglin T, Tait C at al. Guidelines on oral anticoagulation with warfarin 4th edn. Br J Haematol 2011; 153(3); 311\u2013324.","DOI":"10.1111\/j.1365-2141.2011.08753.x"},{"key":"B8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/bdj.2007.892","volume":"203","author":"Perry DJ","year":"2007","journal-title":"Br Dent J"},{"key":"B9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1067\/moe.2002.123828","volume":"94","author":"Scully C","year":"2002","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"B11","first-page":"e14","volume":"2","author":"Gomez-Moreno G","year":"2010","journal-title":"J Clin Exp Dent"},{"key":"B12","unstructured":"National Institute for Health and Clinical Excellence (NICE). Technology Appraisal guidance 157: Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults. London: NICE, September 2008."},{"key":"B13","unstructured":"National Institute for Health and Clinical Excellence (NICE). Technology Appraisal guidance 249: Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation. London: NICE, March 2012."},{"key":"B16","volume-title":"Medical Pharmacology","author":"Constable S","year":"2007","edition":"3"},{"issue":"4","key":"B17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.bdj.4810434","volume":"193","author":"Greenwood M","year":"2003","journal-title":"Br Dent J"},{"key":"B18","volume-title":"Textbook of Human Disease in Dentistry (Chapter 13)","author":"Greenwood M","year":"2009"}],"container-title":["Dental Update"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.magonlinelibrary.com\/doi\/pdf\/10.12968\/denu.2014.41.5.395","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T17:37:18Z","timestamp":1653413838000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.magonlinelibrary.com\/doi\/10.12968\/denu.2014.41.5.395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,2]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,6,2]]}},"alternative-id":["10.12968\/denu.2014.41.5.395"],"URL":"https:\/\/doi.org\/10.12968\/denu.2014.41.5.395","relation":{},"ISSN":["0305-5000","2515-589X"],"issn-type":[{"value":"0305-5000","type":"print"},{"value":"2515-589X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,2]]}}}